Comparison of the systemic bioavailability of mometasone furoate after oral inhalation from a mometasone furoate/formoterol fumarate metered-dose inhaler versus a mometasone furoate dry-powder inhaler in patients with chronic obstructive pulmonary disease

BACKGROUND: Coadministration of mometasone furoate (MF) and formoterol fumarate (F) produces additive effects for improving symptoms and lung function and reduces exacerbations in patients with asthma and chronic obstructive pulmonary disease (COPD). The present study assessed the relative systemic...

Description complète

Enregistré dans:
Détails bibliographiques
Auteurs principaux: Kosoglou, Teddy, Hubbell, James, Xuan, Fengjuan, Cutler, David L, Meehan, Alan G, Kantesaria, Bhavna, Wittmer, Bret A
Format: Artigo
Langue:Inglês
Publié: Dove Medical Press 2013
Sujets:
Original Research
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC3595976/
https://ncbi.nlm.nih.gov/pubmed/23525511
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/COPD.S36592
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires